Literature DB >> 20153978

Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood.

Jaime M Knopman1, Esperenza B Papadopoulos, James A Grifo, M Elizabeth Fino, Nicole Noyes.   

Abstract

Annually, more than 50,000 cancer diagnoses are made in the USA in patients under the age of 35 years. Despite this staggering statistic, medical advancements have substantially improved survival rates. Thus, for both male and female patients with cancer, quality-of-life issues, such as fertility preservation and parenthood, have become an essential component of treatment. Unfortunately, many of the treatments to eradicate malignant processes can also compromise reproductive function. In these cases, fertility preservation should be discussed and initiated with early treatment planning, to allow the best chance for future parenthood, when appropriate. The effects of cancer and cancer treatments on fertility and future parenthood, including health risks for patients, their gametes, and offspring are discussed. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20153978     DOI: 10.1016/S1470-2045(09)70317-1

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  19 in total

1.  Hypothyroidism after cancer and the ability to meet reproductive goals among a cohort of young adult female cancer survivors.

Authors:  Helen B Chin; Melanie H Jacobson; Julia D Interrante; Ann C Mertens; Jessica B Spencer; Penelope P Howards
Journal:  Fertil Steril       Date:  2015-10-30       Impact factor: 7.329

2.  Oocyte cryopreservation: a feasible fertility preservation option for reproductive age cancer survivors.

Authors:  Nicole Noyes; Patty Ann Labella; James Grifo; Jaime M Knopman
Journal:  J Assist Reprod Genet       Date:  2010-05-18       Impact factor: 3.412

3.  Oncofertility in Canada: the impact of cancer on fertility.

Authors:  R Ronn; H E G Holzer
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

4.  Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer.

Authors:  Joseph M Letourneau; James F Smith; Erin E Ebbel; Amaranta Craig; Patricia P Katz; Marcelle I Cedars; Mitchell P Rosen
Journal:  Cancer       Date:  2012-03-26       Impact factor: 6.860

Review 5.  Current approach to fertility preservation by embryo cryopreservation.

Authors:  Giuliano Bedoschi; Kutluk Oktay
Journal:  Fertil Steril       Date:  2013-03-25       Impact factor: 7.329

Review 6.  Ovarian and Uterine Functions in Female Survivors of Childhood Cancers.

Authors:  Ozgur Oktem; Samuel S Kim; Ugur Selek; Glenn Schatmann; Bulent Urman
Journal:  Oncologist       Date:  2017-11-20

7.  Embryo banking among women diagnosed with cancer: a pilot population-based study in New York, Texas, and Illinois.

Authors:  Barbara Luke; Morton B Brown; Logan G Spector; Judy E Stern; Yolanda R Smith; Melanie Williams; Lori Koch; Maria J Schymura
Journal:  J Assist Reprod Genet       Date:  2016-02-03       Impact factor: 3.412

8.  Experiences in fertility preservation: lessons learned to ensure that fertility and reproductive autonomy remain options for cancer survivors.

Authors:  Nicole Noyes; Katherine Melzer; Sarah Druckenmiller; M Elizabeth Fino; Meghan Smith; Jaime M Knopman
Journal:  J Assist Reprod Genet       Date:  2013-08-13       Impact factor: 3.412

9.  Attitudes and Perceptions of Parenthood Among Young Adult Survivors of Childhood Cancer.

Authors:  Alexandra C Himelhoch; Taylor M Datillo; Marrit A Tuinman; Cynthia A Gerhardt; Vicky Lehmann
Journal:  J Adolesc Young Adult Oncol       Date:  2021-05-17       Impact factor: 2.223

10.  Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer.

Authors:  Isabelle Soerjomataram; Joannie Lortet-Tieulent; Jacques Ferlay; David Forman; Colin Mathers; D Maxwell Parkin; Freddie Bray
Journal:  BMC Med Res Methodol       Date:  2012-08-17       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.